We use essential cookies to make this website work and to help improve it for you.
Change website language
Cymraeg – Newid yr iaith ir Gymraeg
English
Home
Many aspects of drug handling are altered in patients with increased body weight whopresent with infection, risking therapeutic failure and antimicrobial resistance due toinadequate drug exposure. Conversely, in underweight patients, […]
Daptomycin is a cyclic lipopeptide antibiotic with potent bactericidal activity against Gram positive organisms including streptococci, coagulase negative staphylococci and Staphylococcus aureus, including methicillin resistant Staphylococcus aureus (MRSA) and glycopeptide […]
The polymyxin antibiotic Colistimethate Sodium (CMS) is indicated for the treatment of seriousinfections caused by selected, extensively resistant Gram-negative bacteria (for example; primarilyextensively resistant Pseudomonas, Acinetobacter and Enterobacterales) in patients […]
The following Infection Prevention and Control (IP&C) Audit Tool aims to encourage self-assessment of Childcare and Education settings in Wales to promote evidence-based/best practice infection prevention and control standards, therefore […]
The final All Wales Neonatal Unit Gentamicin IV monograph approved by All Wales Antimicrobial Guideline Group.
This guideline does not apply to patients receiving renal replacement therapies. For these patients, please contact the Pharmacy Department for advice.
Here you will find information on the antenatal screening tests you will be offered. You will usually get result of your screening blood tests at your 16 week antenatal visit. […]
Information for Clostridioides difficile (C. diff) patients who have been prescribed antibiotics.
